BLRX
BioLineRX
BLRX
BLRX
28 hedge funds and large institutions have $4.01M invested in BioLineRX in 2021 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 8 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
70% less capital invested
Capital invested by funds: $13.5M → $4.01M (-$9.44M)
75% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 8
Holders
28
Holding in Top 10
–
Calls
$86K
Puts
$92K
Top Buyers
| 1 | +$854K | |
| 2 | +$127K | |
| 3 | +$58K | |
| 4 |
VF
Virtu Financial
New York
|
+$47K |
| 5 |
Millennium Management
New York
|
+$42K |
Top Sellers
| 1 | -$7.65M | |
| 2 | -$1.2M | |
| 3 | -$558K | |
| 4 |
Morgan Stanley
New York
|
-$482K |
| 5 |
PVH
Psagot Value Holdings
Tel Aviv,
Israel
|
-$326K |